Joana Duarte-Neves

Joana Duarte-Neves

Auto-generated profile, based on publicly available information

Joana Duarte-Neves

CNC—Center for Neuroscience and Cell Biology University of Coimbra Coimbra Portugal

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2016 in Nature Communications
Verified
Journal Article
Open access
JCJanete Cunha-Santos
Janete Cunha-Santos
JDJoana Duarte-Neves
Joana Duarte-Neves
VCVitor Carmona
Vitor Carmona
LGLeonard Guarente
Leonard Guarente
LALuis Pereira De Almeida
Luis Pereira De Almeida
CCCláudia Cavadas
Cláudia Cavadas
Machado–Joseph disease (MJD) is a neurodegenerative disorder characterized by an abnormal expansion of the CAG triplet in the ATXN3 gene, translating into a polyglutamine tract within the ataxin-3 protein. The available treatments only ameliorate symptomatology and do not block disease progression. In this study we find that caloric restriction dramatically rescues the motor incoordination, imbalance and the associated neuropathology in transgenic MJD mice. We further show that caloric restriction rescues SIRT1 levels in transgenic MJD mice, whereas silencing SIRT1 is sufficient to prevent the beneficial effects on MJD pathology. In addition, the re-establishment of SIRT1 levels in MJD mouse model, through the gene delivery approach, significantly ameliorates neuropathology, reducing neuroinflammation and activating autophagy. Furthermore, the pharmacological activation of SIRT1 with resveratrol significantly reduces motor incoordination of MJD mice. The pharmacological SIRT1 activation could provide important benefits to treat MJD patients.

27 July 2015 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
JDJoana Duarte-Neves
Joana Duarte-Neves
NGNélio Gonçalves
Nélio Gonçalves
JCJanete Cunha-Santos
Janete Cunha-Santos
ASAna Teresa Simões
Ana Teresa Simões
WDWilfred F.A. Den Dunnen
Wilfred F.A. Den Dunnen
LALuis Pereira De Almeida
Luis Pereira De Almeida
Machado–Joseph disease (MJD) is a fatal, dominantly inherited neurodegenerative disorder associated with an expanded polyglutamine tract within the ataxin-3 protein, and characterized by progressive impairment of motor coordination, associated with neurodegeneration of specific brain regions, including cerebellum and striatum. The currently available therapies do not allow modification of disease progression. Neuropeptide Y (NPY) has been shown to exert potent neuroprotective effects by multiple pathways associated with the MJD mechanisms of disease. Thus, we evaluated NPY levels in MJD and investigated whether raising NPY by gene transfer would alleviate neuropathological and behavioural deficits in cerebellar and striatal mouse models of the disease. For that, a cerebellar transgenic and a striatal lentiviral-based models of MJD were used. NPY overexpression in the affected brain regions in these two mouse models was obtained by stereotaxic injection of adeno-associated viral vectors encoding NPY. Up to 8 weeks after viral injection, balance and motor coordination behaviour and neuropathology were analysed. We observed that NPY levels were decreased in two MJD patients' cerebella and in striata and cerebella of disease mouse models. Furthermore, overexpression of NPY alleviated the motor coordination impairments and attenuated the related neuropathological parameters, preserving cerebellar volume and granular layer thickness, reducing striatal lesion and decreasing mutant ataxin-3 aggregation. Additionally, NPY mediated increase of brain-derived neurotrophic factor levels and decreased neuroinflammation markers. Our data suggest that NPY is a potential therapeutic strategy for MJD.

17 July 2021 in Neuropathology and Applied Neurobiology
Verified
Journal Article
Closed access
PDF file
ASAna Teresa Simões
Ana Teresa Simões
VCVítor Carmona
Vítor Carmona
JDJoana Duarte‐Neves
Joana Duarte‐Neves
JCJanete Cunha‐Santos
Janete Cunha‐Santos
LALuis Pereira De Almeida
Luis Pereira De Almeida